Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 79, Issue 1, 1998, Pages

  Carnielli, Virgilio P ^a   Da Riol, Rosalia ^a   Montini, Giovanni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Anaemia of prematurity; Erythropoietin; Iron supplementation; Transfusion

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROPOIESIS; HUMAN; INFANT; INFANT DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TREATMENT OUTCOME;

EID: 0031852009     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.79.1.F44     Document Type: Article

References (38)

1. Strauss RG. Erythropoietin and neonatal anemia. N Engl J Mad 1994;33:1227-8.
2. Strauss RG. Transfusion therapy in neonates. Am J Dis Child 1991;145:904-11.
3. Shannon KM. Anemia of prematurity: progress and prospects. Am J Pediatr Hematol 1990;12:14-20.
4. Shannon K, Keith J, Mentzer B, Phibbs R. Recombinant erythropoietin in anemia of prematurity: five years later. Pediatrics 1993;92:614-17.
5. Stockman JA, Garcia JF, Oski FA. The anemia of prematurity: Factors governing the erythropoietin response. N Engl J Med 1977;296:647-50.
6. Emmerson AJB, Wesrwood NB, Rackham RA, Stern CMM, Pearson TC. Erythropoietin responsive progenitors in anaemia of prematurity. Arch Dis Child 1991;66:273-5.
7. Emmerson AJB. Role of erythropoietin in the newborn. Arch Dis Child 1993;69:273-5.
8. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA. Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the "anemia of prematurity". J Pediatr 1988;112:935-40.
9. Beck D, Masserey E, Meyer M, Calame A. Weekly intravenous asdministration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr 1991;150:767-72.
10. Obladen M, Maier R, Segerer H, et al. Efficacy and safety of recombinant human erythropoietin to prevent the anaemias of prematurity. Contrib Nephrol 1991;88:314-26.
11. Shannon KM, Mentzer WC, Abels RI, et al. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study. J Pediatr 1992;120:586-92.
12. Halperin DS, Felix M, Wacker P, Lacourt G, Babel JF, Wyss M. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity. Eur J Pediatr 1992;151:661-7.
13. Carnielli VP, Montini G, DaRiol R, Dall'Amico R, Cantarutti F. Effect of high dose of human recombinant erythropoietin on the need for blood transfusions in preterm infants. J Pediatr 1992;121:98-102.
14. Emmerson AJB, Coles HJ, Stern MM, Pearson TC. Double blind trial on recombinant human erythropoietin in preterm infants. Arch Dis Child 1993;68:291-6.
15. Messer J, Haddad J, Donato L, Astruc D, Matis J. Early treatment of premature infants with recombinant human erythropoietin. Pediatrics 1993;92:519-23.
16. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 1994;330:1173-88.
17. Gallagher PG, Ehrenkranz RA. Erythropoietin therapy for anemia of prematurity. Clin Perinatol 1993;20:169-91.
18. Shannon KM, Keith JFI, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduce erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-10.
19. Ohls RK, Veerman MW, Christensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continous infusion in total parenteral nutrition solution. J Pediatr 1996;128:518-23.
20. Meyer MP, Haworth C, Meyer JH, Cammerford A. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr 1996;129:258-63.
21. Maier RF, Obladen M, Messinger D, Wardrop CAJ. Factors related to transfusion in very low birthweight infants treated with erythropoietin. Arch Dis Child 1996;74:F182-F6.
22. Shannon KM, Mentzer WC, Abels RI, et al. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 1991;118:949-55.
23. Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity ? Results of a randomized controlled study. Pediatr Res 1993;34:675-9.
24. Carnielli VP, Da Riol R, Montini G. Recombinant erythropoietin in very-low-birth-weight infants. N Engl J Med 1994;331:677
25. Montini G, Zacchello G, Perfumo F, et al. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: A multicenter study. J Pediatr 1993;122:297-302.
26. Bechensteen AG, Haga P, Halvorsen S, et al. Erythropoietin, protein and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child 1993;69:19-23.
27. Halperin DS, Wacker P, Lacourt G, et al. Effect of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 1990;116:779-86.
28. Meyer MP, Meyer JH, Commerford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 1994;93:918-23.
29. Brugnara C, Chambers LA, Mlynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects. Blood 1993;81:956-64.
30. Finch CA. Erythropoiesis, erythropoietin, and iron. Blood 1982;60:1241-6.
31. England JM, Ward SM, Down MC. Microcytosis, anisocytosis and the red cell indices in iron deficiency. Br J Haematol 1976;34:589-93.
32. Conrad ME, Crosby Crosby WH. The natural hystory of iron deficiency induced by phlebotomy. Blood 1962;20:173-7.
33. Kinmond S, Aitchinson TC, Holland BM, Jones JG, Turner TL, Wardrop CAJ. Umbilical cord clamping and preterm infants: a randomised trial. BMJ 1993;306:172-5.
34. Pisacane A. Neonatal prevention of iron deficiency. BMJ 1996;312:136-7.
35. Kivivuori SM, Heikinheimo M, Teppo AM, Siimes MA. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res 1994;36:85-9.
36. Beguin Y. The soluble transferrin receptor: biological aspects and clinical useulness as quantitative measure of erythropoiesis. Haematologica 1992;77:1-10.
37. Macdougall IC, Cavill I, Hulme B, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 1992;304:225-6.
38. Sullivan JL. Iron, plasma antioxidants, and the oxygen radical disease of prematurity. Am J Dis Child 1988;142:1341-4.